From the JP Morgan Conference: The Impact of the Inflation Reduction Act
John was at the JP Morgan conference and is here to discuss the key takeaways of the Inflation Reduction Act: the small-molecule penalty, the value of small-molecule drugs, the importance of incentivizing post-approval research, intellectual property, and non-coverage decisions at CMS. You’ll also hear John’s take on the demand for a more pro-patient agenda. There was a lot of focus on the role of policy and government, specifically in relation to the inflation reduction act and its impact on the life science and venture capital industries.
Ready to reaffirm its values, Incubate will be…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.